Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_assertion type Assertion NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_head.
- NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_assertion description "[To enhance the immunogenecity of CEA, we developed a fusion gene (CRT-TAT-DeltaCEA) of the TAT protein transduction domain (PTD) and calreticulin (CRT) with human CEA devoid of its signal sequences (DeltaCEA) and evaluated anti-tumor immunity using RNA-pulsed dendritic cell (DC) vaccination.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_provenance.
- NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_assertion evidence source_evidence_literature NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_provenance.
- NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_assertion SIO_000772 18812201 NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_provenance.
- NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_assertion wasDerivedFrom befree-2016 NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_provenance.
- NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_assertion wasGeneratedBy ECO_0000203 NP694544.RAJFHotZ5N2y6O4-J8bPbwEWQHzqvRHwnYIbpt4UA3Sn4130_provenance.